Age Disparity in the Dissemination of Imatinib for Treating Chronic Myeloid Leukemia

BACKGROUND: Imatinib is a highly effective treatment for chronic myeloid leukemia (CML) that was approved by the Food and Drug Administration in 2001, and thereafter rapidly became front line therapy. This study characterized the prevailing chronic myeloid leukemia therapies in the United States and...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wiggins, Charles L., Harlan, Linda C., Nelson, Harold E., Stevens, Jennifer L., Willman, Cheryl L., Libby, Edward N., Hromas, Robert A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913144/
https://ncbi.nlm.nih.gov/pubmed/20670732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2010.03.018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky